Along with MND Association and MND Scotland, we have funded Consultant Neuropathologist Professor Willie Stewart, to examine the relationship between traumatic brain injury (TBI) and the risk of developing motor neuron disease (MND). Professor Stewart and his team have recently published their findings.

Researchers have been studying the possible association between TBI and MND for a while, but no conclusions have, so far, been made.

Using UK-wide electronic health records from more than 340,000 adults between 2005 and 2020, the researchers found that individuals with a history of TBI were over twice as likely to receive a subsequent MND diagnosis compared with matched individuals without a history of TBI. However, it is important to note that this risk was confined to the first two years following the injury; after those two years no long-term risk was observed.

As the increased risk was mostly seen during the two years immediately after the injury, it suggests that TBI might be an early sign of MND rather than a cause of the disease. This is because there is the potential for someone who has not yet been diagnosed with MND but is at the earliest stages of the disease to be unsteady on their feet, which may mean they’re more likely to fall and suffer a TBI.

This research has provided a new understanding of the potential link between TBI and MND and represents one of the most comprehensive population-level studies in this area to date.

These observations highlight the very complex relationship between head injury and risk of MND. The possibility that TBI might be an early indicator of developing MND is an important finding and might suggest increased surveillance in highest risk patient populations may be of benefit.

Professor Willie Stewart

Consultant Neuropathologist

We will continue to collaborate with our funding partners and the research community to uncover the underlying causes of MND to enable faster diagnosis.

More news & stories

View all
 picture
Research
23 Sep 2026

Topline announcement of Phase 3 trial results for FUS-MND appear promising

Yesterday, the companies Otsuka and Ionis announced the results of their Phase 3 trial of the genetic therapy, ulefnersen. Ulefnersen targets a rare form of MND…
Read more
 picture
MND stories Research
14 Sep 2026

R.A.C.E. to Diagnose: New training programme to speed up MND diagnosis

For Andy Vaughton, receiving a motor neuron disease (MND) diagnosis in 2021 finally provided an answer for symptoms he had been struggling with for several years.…
Read more
 picture
Fundraising MND stories
10 Sep 2026

"I love you, and this is for you": Cammy cycles over 1,000 miles in memory of his Dad

This year, Cammy Jones has taken on two long-distance cycling challenges for My Name’5 Doddie Foundation: Doddie’s Triple Crown, which saw him ride from Melrose…
Read more
Bell icon

Join our Newsletter!

By subscribing, you confirm that you agree with our terms and conditions.